Cochrane Abstracts
Antipsychotic switching for people with schizophrenia who have neuroleptic‐induced weight or metabolic problems
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Antipsychotic Switching for People With Schizophrenia Who Have Neuroleptic‐induced Weight or Metabolic Problems." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/433999/all/Antipsychotic_switching_for_people_with_schizophrenia_who_have_neuroleptic‐induced_weight_or_metabolic_problems.
Antipsychotic switching for people with schizophrenia who have neuroleptic‐induced weight or metabolic problems. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433999/all/Antipsychotic_switching_for_people_with_schizophrenia_who_have_neuroleptic‐induced_weight_or_metabolic_problems. Accessed May 17, 2025.
Antipsychotic switching for people with schizophrenia who have neuroleptic‐induced weight or metabolic problems. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433999/all/Antipsychotic_switching_for_people_with_schizophrenia_who_have_neuroleptic‐induced_weight_or_metabolic_problems
Antipsychotic Switching for People With Schizophrenia Who Have Neuroleptic‐induced Weight or Metabolic Problems [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 May 17]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/433999/all/Antipsychotic_switching_for_people_with_schizophrenia_who_have_neuroleptic‐induced_weight_or_metabolic_problems.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Antipsychotic switching for people with schizophrenia who have neuroleptic‐induced weight or metabolic problems
ID - 433999
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/433999/all/Antipsychotic_switching_for_people_with_schizophrenia_who_have_neuroleptic‐induced_weight_or_metabolic_problems
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
